More reads
- How Democrats are explaining Congress’s lack of progress on drug prices. (STAT)
- Who is next in big pharma's merger spree? (Reuters)
- Novartis CEO Battles Fallout From Data Manipulation. (Wall Street Journal)
- AIDS activists say Gilead misled Congress about an HIV pill. (STAT Plus)
No hay comentarios:
Publicar un comentario